Fundraising FoxExcision BioTherapeutics Inc.
San Francisco, US · 8 known investors
Find your way into Excision BioTherapeutics Inc.
Sign up to see every warm intro you have to Excision BioTherapeutics Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Excision BioTherapeutics Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 8
How we know: av.vc · Not right? Tell us
How we know: Anzu Partners's portfolio page · funding news · Not right? Tell us
How we know: Cota Capital's portfolio page · Not right? Tell us
__Twitter.png)
How we know: Olive Tree Capital's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$71.2M disclosed across 2 rounds · 2021
▶$10.5MraisedMar 2021 · 6 investors · BiotechnologyRule 506(b)
- Vasudev BaileyDirector
- Ashok KrishnamurthiDirector
- William CarsonDirector
- Daniel DornbuschExecutive Officer, Director
- Offering amount
- $10.5M
- Amount sold
- $10.5M
- Minimum investment
- $1
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60.7MraisedFeb 2021 · 32 investors · BiotechnologyRule 506(b)
- Daniel DornbuschExecutive Officer, Director
- Vasudev BaileyDirector
- William CarsonDirector
- Ashok KrishnamurthiDirector
- Offering amount
- $63.8M
- Amount sold
- $60.7M
- Minimum investment
- $1
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $217.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Excision BioTherapeutics Inc.'s investors?
- Excision BioTherapeutics Inc.'s investors include Alumni Ventures, Anzu Partners, Cota Capital, Gaingels, Olive Tree Capital, Adjuvant Capital, Artis Ventures, GreatPoint Ventures.
- How much funding has Excision BioTherapeutics Inc. raised?
- Excision BioTherapeutics Inc. has disclosed $71.2M raised across 2 rounds.
- Where is Excision BioTherapeutics Inc. headquartered?
- Excision BioTherapeutics Inc. is headquartered in San Francisco, US.